000 01291 a2200325 4500
005 20250516082417.0
264 0 _c20120702
008 201207s 0 0 eng d
022 _a1949-2553
024 7 _a10.18632/oncotarget.439
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPabla, Navjotsingh
245 0 0 _aCurtailing side effects in chemotherapy: a tale of PKCĪ“ in cisplatin treatment.
_h[electronic resource]
260 _bOncotarget
_cJan 2012
300 _a107-11 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Review
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xadverse effects
650 0 4 _aCisplatin
_xadministration & dosage
650 0 4 _aCytoprotection
_xdrug effects
650 0 4 _aDrug-Related Side Effects and Adverse Reactions
_xgenetics
650 0 4 _aHumans
650 0 4 _aKidney Diseases
_xchemically induced
650 0 4 _aNeoplasms
_xdrug therapy
650 0 4 _aProtein Kinase C-delta
_xgenetics
650 0 4 _aSignal Transduction
_xgenetics
700 1 _aDong, Zheng
773 0 _tOncotarget
_gvol. 3
_gno. 1
_gp. 107-11
856 4 0 _uhttps://doi.org/10.18632/oncotarget.439
_zAvailable from publisher's website
999 _c21609115
_d21609115